Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Dynacure SA ADR (DYCU)

NASDAQ
Currency in USD
Disclaimer
0.00
0.00(0.00%)
Closed
Fair Value
Unlock Value
Day's Range
0.000.00
52 wk Range
0.000.00
Prev. Close
-
Open
-
Day's Range
-
52 wk Range
0-0
Volume
0
Average Volume (3m)
-
1-Year Change
-
Shares Outstanding
-
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about DYCU?
Vote to see community's results!
or

Dynacure SA ADR Company Profile

DYNACURE S.A., a clinical-stage biotechnology company, engages in developing and commercializing novel therapies for rare diseases. The company focuses on developing therapies for the treatment of neuromuscular diseases, such as myotubular, and centronuclear myopathies (CNM), a group of devastating rare genetic disorders. Its lead product candidate is DYN101, an antisense oligonucleotide (ASO) that is in Phase 1/2 clinical trials for the treatment and other neuromuscular diseases. The company also develops DYN201, a discovery-stage program for the treatment of a group of rare inherited neurodegenerative disorders, such as hereditary spastic paraplegias. It has a research collaboration and license agreement with the Institut Du Cerveau et de la Moelle Epiniere to discover, develop, and commercialize a treatment approach for hereditary spastic paraplegia type 11. DYNACURE S.A. was incorporated in 2016 and is based in Illkirch-Graffenstaden, France. As of May 1, 2023, Dynacure S.A. operates as a subsidiary of Flamingo Therapeutics BV.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.